Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Smoking Cessation Health Center

Font Size

FDA: Chantix Benefits Still Outweigh the Risks

Stop-Smoking Drug Doesn't Raise Risk of Psychiatric Hospitalization, Study Shows
WebMD Health News
Reviewed by Laura J. Martin, MD

Oct. 24, 2011 -- New studies show that the benefits of the stop-smoking drug Chantix still outweigh its risks, the FDA says.

The FDA-sponsored studies find that Chantix does not increase a person's risk of psychiatric hospitalization. But the studies "do not rule out an increased risk of other neuropsychiatric events with Chantix," the FDA says in a statement.

This means that warnings on the current Chantix label are strong enough for the FDA.

"The Agency continues to believe that the drug's benefits outweigh the risks and the current warnings in the Chantix label are appropriate," the FDA says.

In 2009, the FDA required Chantix -- and Zyban, a different kind of stop-smoking drug -- to warn users of the risk of "serious psychiatric symptoms." These include behavior changes, hostility, agitation, depressed mood, suicidal thoughts, and attempted suicide.

More recently, the FDA warned that Chantix may add to the risk of heart attack in people with underlying heart disease.

However, the benefits of quitting smoking are enormous. And clinical trials show that Chantix greatly increases a smoker's odds of kicking the habit.

The FDA cited two studies. In the first, the Veterans Administration compared over 14,000 Chantix users to people trying to quit smoking by using a nicotine patch or other nicotine replacement therapies (NRTs). In the second, the Department of Defense compared nearly 20,000 Chantix users to some 16,000 NRT users.

Overall, the studies found no increased risk of psychiatric hospitalization in Chantix users. However, the Department of Defense study followed patients for only 30 days. And neither study looked at psychiatric symptoms that were not serious enough to require hospitalization.

Pfizer, which makes Chantix, is conducting a large safety study to look more closely at the drug's psychiatric risks. Results of that study should be announced in 2017.

Chantix works by partially blocking nicotine receptors in the brain. This takes away much of the rewarding effect of smoking. Chantix also mimics the effects of nicotine on the brain, although to a lesser extent than nicotine itself.

Today on WebMD

hands breaking a cigarette
Is quitting cold turkey an effective method?
14 tips to get you through the first hard days.
smoking man
Surprising impacts of tobacco on the body.
cigarette smoke
What happens when you kick the habit?

Filtered cigarettes
an array of e cigarettes
human heart
Woman experiencing withdrawal symptoms

man smoking cigarette
no smoking sign
Woman ashing cigarette in ashtray
chain watch